Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials.
about
Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Impact of genetic variations i ...... from FIRE-3 and TRIBE trials.
@en
Impact of genetic variations i ...... from FIRE-3 and TRIBE trials.
@nl
type
label
Impact of genetic variations i ...... from FIRE-3 and TRIBE trials.
@en
Impact of genetic variations i ...... from FIRE-3 and TRIBE trials.
@nl
prefLabel
Impact of genetic variations i ...... from FIRE-3 and TRIBE trials.
@en
Impact of genetic variations i ...... from FIRE-3 and TRIBE trials.
@nl
P2093
P2860
P50
P356
P1433
P1476
Impact of genetic variations i ...... from FIRE-3 and TRIBE trials.
@en
P2093
M D Berger
S Matsusaka
V Heinemann
P2860
P304
P356
10.1093/ANNONC/MDX412
P577
2017-08-02T00:00:00Z